News

Category

Year

2024.07.01News Release

Maruho and Sibel Health Enter into a Worldwide Collaborative Development and Commercialization Agreement for a New Digital Health Technology for Itch

2024.06.11News Release

Maruho Launches "Mitchga Subcutaneous Injection 30mg Vials", an Antibody Treatment for Pruritus Associated with Atopic Dermatitis (Pediatric) and Prurigo Nodularis in Japan

2024.06.05News Release

Maruho and Hyphens Pharma Announce Exclusive License Agreement for Anti-herpes Virus Agent (INN: Amenamevir) in 10 ASEAN Countries

2024.03.26News Release

Maruho Acquires Manufacturing and Marketing Approval in Japan for "Mitchga Subcutaneous Injection 30mg Vials", an Antibody Treatment for Pruritus Associated with Atopic Dermatitis (Pediatric) and Prurigo Nodularis

2024.02.22News Release

Maruho Establishes Local Subsidiary in China

2024.01.10News Release

AOBiome and Maruho have entered into an Exclusive License Agreement for a Novel Therapeutic for the treatment of Atopic Dermatitis in Japan

1